<\/p>\n
Cyblex MV<\/strong> \u0435 \u0442\u0440\u043e\u0439\u043d\u0430 \u043a\u043e\u043c\u0431\u0438\u043d\u0430\u0446\u0438\u044f \u0441 \u0444\u0438\u043a\u0441\u0438\u0440\u0430\u043d\u0430 \u0434\u043e\u0437\u0430<\/strong> \u043e\u0442 metformin, gliclazide and voglibose<\/strong> (Metformin 500 mg + Gliclazide 80 mg + Voglibose 0.2 mg) used for \u0434\u0438\u0430\u0431\u0435\u0442 \u0442\u0438\u043f 2<\/strong> not controlled on dual therapy. Three complementary mechanisms in a single tablet: metformin reduces hepatic glucose production; gliclazide (a second-generation sulfonylurea) stimulates insulin release; voglibose slows intestinal carbohydrate absorption to blunt post-meal spikes. Typical HbA1c reduction: 2.0\u20132.5 \u043f\u0443\u043d\u043a\u0442\u0430<\/strong>. Usual dose: one tablet 1–3 times daily with the first bite of each main meal. Side-effect profile combines hypoglycaemia risk (gliclazide), GI flatulence\/bloating (voglibose), and metformin GI upset. Hypoglycaemia rescue requires glucose (dextrose) tablets<\/strong>, not table sugar (voglibose blocks sucrose breakdown). Avoid in type 1 diabetes, eGFR < 30, IBD, severe hepatic impairment, and sulfa allergy.<\/p>\n<\/div>\n \ud83d\udce6 \u0412\u0441\u044f\u043a\u0430 \u043f\u043e\u0440\u044a\u0447\u043a\u0430 \u0435 \u043f\u043e\u043a\u0440\u0438\u0442\u0430 \u043e\u0442 \u043d\u0430\u0448\u0430\u0442\u0430 \u041f\u043e\u043b\u0438\u0442\u0438\u043a\u0430 \u0437\u0430 \u043f\u043e\u0432\u0442\u043e\u0440\u043d\u0430 \u0438\u0437\u043f\u0440\u0430\u0442\u043a\u0430<\/strong><\/a> \u2014 \u0430\u043a\u043e \u0432\u0430\u0448\u0430\u0442\u0430 \u043f\u0440\u0430\u0442\u043a\u0430 \u043d\u0435 \u043f\u0440\u0438\u0441\u0442\u0438\u0433\u043d\u0435 \u0432 \u0440\u0430\u043c\u043a\u0438\u0442\u0435 \u043d\u0430 20 \u0440\u0430\u0431\u043e\u0442\u043d\u0438 \u0434\u043d\u0438, \u043d\u0438\u0435 \u044f \u0438\u0437\u043f\u0440\u0430\u0449\u0430\u043c\u0435 \u043e\u0442\u043d\u043e\u0432\u043e.<\/p>\n \u041d\u0430\u0448\u0438\u0442\u0435 \u0433\u0435\u043d\u0435\u0440\u0438\u0447\u043d\u0438 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0430 \u0441\u0435 \u0434\u043e\u0441\u0442\u0430\u0432\u044f\u0442 \u043e\u0442 \u043f\u0440\u043e\u0438\u0437\u0432\u043e\u0434\u0438\u0442\u0435\u043b\u0438, \u0441\u0435\u0440\u0442\u0438\u0444\u0438\u0446\u0438\u0440\u0430\u043d\u0438 \u043e\u0442 WHO-GMP, \u0438 \u0441\u0435 \u0438\u0437\u043f\u0440\u0430\u0449\u0430\u0442 \u043f\u043e \u0446\u0435\u043b\u0438\u044f \u0441\u0432\u044f\u0442 \u0432 \u0434\u0438\u0441\u043a\u0440\u0435\u0442\u043d\u0430, \u043e\u0431\u0438\u043a\u043d\u043e\u0432\u0435\u043d\u0430 \u043e\u043f\u0430\u043a\u043e\u0432\u043a\u0430 \u2014 \u0431\u0435\u0437 \u0438\u043c\u0435 \u043d\u0430 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e\u0442\u043e \u0432\u044a\u043d\u0448\u043d\u043e \u043d\u0430 \u043f\u0440\u0430\u0442\u043a\u0430\u0442\u0430. \u041f\u043b\u0430\u0449\u0430\u043d\u0438\u044f\u0442\u0430 \u0441 \u043a\u0430\u0440\u0442\u0430 \u0441\u0435 \u043e\u0431\u0440\u0430\u0431\u043e\u0442\u0432\u0430\u0442 \u0447\u0440\u0435\u0437 \u0440\u0435\u0433\u0443\u043b\u0438\u0440\u0430\u043d \u043f\u0440\u043e\u0446\u0435\u0441\u043e\u0440 (\u043e\u043f\u0438\u0441\u0430\u043d\u0438\u0435\u0442\u043e \u043d\u0430 \u0438\u0437\u0432\u043b\u0435\u0447\u0435\u043d\u0438\u0435\u0442\u043e \u0432\u043a\u043b\u044e\u0447\u0432\u0430 \u0440\u0435\u0433\u0443\u043b\u0438\u0440\u0430\u043d \u043f\u0440\u043e\u0446\u0435\u0441\u043e\u0440 \u0437\u0430 \u043f\u043b\u0430\u0449\u0430\u043d\u0435 \u0441 \u043a\u0430\u0440\u0442\u0430 \u2014 \u043d\u0438\u043a\u043e\u0433\u0430 \u201cMedsBase\u201d \u0438\u043b\u0438 \u0438\u043c\u0435 \u043d\u0430 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u043e). \u041f\u0440\u0438\u0435\u043c\u0430\u0442 \u0441\u0435 \u0441\u044a\u0449\u043e \u043a\u0440\u0438\u043f\u0442\u043e\u0432\u0430\u043b\u0443\u0442\u0438 \u0438 \u0431\u0430\u043d\u043a\u043e\u0432 \u043f\u0440\u0435\u0432\u043e\u0434 SEPA. \u0412\u0441\u044f\u043a\u0430 \u043f\u043e\u0440\u044a\u0447\u043a\u0430 \u0435 \u043f\u043e\u0434\u043a\u0440\u0435\u043f\u0435\u043d\u0430 \u043e\u0442 \u043d\u0430\u0448\u0430\u0442\u0430 \u043f\u043e\u043b\u0438\u0442\u0438\u043a\u0430 \u0437\u0430 \u0433\u0430\u0440\u0430\u043d\u0442\u0438\u0440\u0430\u043d\u043e \u043f\u0440\u0435\u0438\u0437\u043f\u0440\u0430\u0449\u0430\u043d\u0435.<\/p>\n Cyblex MV is an oral fixed-dose combination tablet containing three active antidiabetic ingredients: metformin, gliclazide and voglibose<\/strong> (Metformin 500 mg + Gliclazide 80 mg + Voglibose 0.2 mg). Manufactured by WHO-GMP certified manufacturer. Available in packs of 30, 60, 90 or 180 tablets. It is used in adults with type 2 diabetes when dual therapy is not enough and the clinician wants to intensify oral treatment before starting insulin.<\/p>\n The three-way combination is especially useful in people with a predominantly carbohydrate-rich diet (Asian populations) where post-meal glucose spikes are a major driver of HbA1c.<\/p>\n Cyblex MV targets hyperglycaemia through three completely separate mechanisms:<\/p>\n Combined HbA1c reduction: 2.0\u20132.5 \u043f\u0440\u043e\u0446\u0435\u043d\u0442\u043d\u0438 \u043f\u0443\u043d\u043a\u0442\u0430<\/strong>. The combination covers fasting, post-meal, and overall insulin-resistance contributions to hyperglycaemia in one tablet.<\/p>\n \u041e\u0431\u0438\u0447\u0430\u0439\u043d\u0430 \u0434\u043e\u0437\u0430:<\/strong> one tablet taken with the first bite of each main meal (once, twice, or three times daily depending on prior regimen and HbA1c target).<\/p>\n \u041e\u0442 \u043c\u0435\u0442\u0444\u043e\u0440\u043c\u0438\u043d (\u043f\u044a\u0440\u0432\u0438 1\u20132 \u0441\u0435\u0434\u043c\u0438\u0446\u0438):<\/strong> diarrhoea, nausea, abdominal cramps, metallic taste.<\/p>\n From gliclazide:<\/strong><\/p>\n From voglibose:<\/strong> flatulence, bloating, soft stools, diarrhoea — usually improves with slow titration.<\/p>\n \u041d\u0435\u0447\u0435\u0441\u0442\u0438, \u043d\u043e \u0441\u0435\u0440\u0438\u043e\u0437\u043d\u0438:<\/strong> lactic acidosis (metformin) — very rare, almost always in AKI\/sepsis\/hypoxia; severe or prolonged hypoglycaemia; hepatic-enzyme elevation; rare haemolytic anaemia in G6PD deficiency.<\/p>\n Store Cyblex MV below 25°C in a dry place. Keep out of reach of children.<\/p>\n To simplify the regimen. Patients needing metformin + sulfonylurea + alpha-glucosidase inhibitor would otherwise take three separate tablets at each meal. Combining them into one tablet improves adherence and reduces pill burden without changing the clinical effect.<\/p>\n No — take pure glucose (dextrose) tablets or gel. Because Cyblex MV contains voglibose, the alpha-glucosidase inhibitor blocks the breakdown of sucrose (table sugar) and many other complex carbohydrates, so they work too slowly for a hypo. Glucose itself is absorbed directly and works within minutes.<\/p>\n Modest 1–2 kg, driven by the gliclazide component. Metformin and voglibose are weight-neutral or very slightly weight-reducing, so the net effect is usually less than sulfonylurea monotherapy.<\/p>\n Moderate alcohol with food is usually safe. Avoid binge drinking — raises hypoglycaemia risk (gliclazide) and lactic acidosis risk (metformin).<\/p>\n A decision for you and your prescriber. Insulin is essential once beta-cell function is severely reduced but has its own risks (hypoglycaemia, weight gain, injections). Triple oral therapy like Cyblex MV is often tried first in motivated patients with residual beta-cell function.<\/p>\n You can order Cyblex MV (Metformin 500 mg + Gliclazide 80 mg + Voglibose 0.2 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n <\/p>\n \u0414\u0440\u0443\u0433\u0438 \u043f\u0440\u043e\u0434\u0443\u043a\u0442\u0438 \u0432 \u0425\u0440\u043e\u043d\u0438\u0447\u043d\u0438 \u0437\u0430\u0431\u043e\u043b\u044f\u0432\u0430\u043d\u0438\u044f<\/strong> \u043a\u043e\u0438\u0442\u043e \u043a\u043b\u0438\u0435\u043d\u0442\u0438\u0442\u0435 \u0441\u044a\u0449\u043e \u0440\u0430\u0437\u0433\u043b\u0435\u0436\u0434\u0430\u0442:<\/p>\n \u2705 \u041a\u043e\u043d\u0442\u0440\u043e\u043b\u0438\u0440\u0430 \u043a\u0440\u044a\u0432\u043d\u0430\u0442\u0430 \u0437\u0430\u0445\u0430\u0440 Cyblex MV contains Metformin, Gliclazide and Voglibose.<\/p>","protected":false},"featured_media":58778,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[4567,3235,3255,3276],"class_list":{"0":"post-58777","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-cyblex-mv","11":"product_tag-gliclazide","12":"product_tag-metformin","13":"product_tag-voglibose","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product\/58777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/comments?post=58777"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/media\/58778"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/media?parent=58777"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product_brand?post=58777"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product_cat?post=58777"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/bg\/wp-json\/wp\/v2\/product_tag?post=58777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\u0417\u0430\u0449\u043e \u0434\u0430 \u043f\u043e\u0440\u044a\u0447\u0432\u0430\u0442\u0435 \u043e\u0442 MedsBase<\/h3>\n
What Is Cyblex MV?<\/h2>\n
How Does Cyblex MV Work?<\/h2>\n
\n
\u0414\u043e\u0437\u0438\u0440\u0430\u043d\u0435 \u0438 \u043f\u0440\u0438\u043b\u0430\u0433\u0430\u043d\u0435<\/h2>\n
\n
\u0421\u0442\u0440\u0430\u043d\u0438\u0447\u043d\u0438 \u0435\u0444\u0435\u043a\u0442\u0438<\/h2>\n
\n
\u041b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u0438 \u0432\u0437\u0430\u0438\u043c\u043e\u0434\u0435\u0439\u0441\u0442\u0432\u0438\u044f<\/h2>\n
\n
Who Should Not Take Cyblex MV?<\/h2>\n
\n
\u0421\u044a\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u0435<\/h2>\n
\u0427\u0435\u0441\u0442\u043e \u0437\u0430\u0434\u0430\u0432\u0430\u043d\u0438 \u0432\u044a\u043f\u0440\u043e\u0441\u0438<\/h2>\n
Why a triple-drug diabetes tablet?<\/h3>\n
If I get low blood sugar, can I just eat a sweet?<\/h3>\n
Does Cyblex MV cause weight gain?<\/h3>\n
Can I drink alcohol while taking Cyblex MV?<\/h3>\n
Should I switch to insulin?<\/h3>\n
Where can I buy Cyblex MV online?<\/h3>\n
\u0421\u0432\u044a\u0440\u0437\u0430\u043d\u0438 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0430 \u0437\u0430 \u0434\u0438\u0430\u0431\u0435\u0442<\/h2>\n
\n
\u0421\u0432\u044a\u0440\u0437\u0430\u043d\u0438 \u0430\u043b\u0442\u0435\u0440\u043d\u0430\u0442\u0438\u0432\u0438<\/h3>\n
\n
\n\u2705 Triple action formula
\n\u2705 Controls diabetes effectively
\n\u2705 Combination therapy
\n\u2705 \u041f\u043e\u0434\u043e\u0431\u0440\u044f\u0432\u0430 \u0438\u043d\u0441\u0443\u043b\u0438\u043d\u043e\u0432\u0430\u0442\u0430 \u0447\u0443\u0432\u0441\u0442\u0432\u0438\u0442\u0435\u043b\u043d\u043e\u0441\u0442<\/p>\n